We studied a collection of 105 clinical enterobacteria with unusual phenotypes of 31 quinolone susceptibility to analyze the occurrence of plasmid mediated quinolone resistance 32 (PMQR) and oqx genes and their implications on quinolone susceptibility. The oqxA and 33 oqxB genes were found in 31/34 (91%) Klebsiella pneumoniae and 1/3 Klebsiella oxytoca. 34 However, the oqxA/oqxB-harboring isolates lacking other known quinolone resistance 35 determinants showed wide ranges of susceptibility to nalidixic acid and ciprofloxacin. Sixty 36 of the 105 (57%) isolates harbored at least one PMQR gene (qnrB19, qnrB10, qnrB2, qnrB1, 37 qnrS1 or aac(6´)-Ib-cr), belong to 8 enterobacterial species, were disseminated throughout the 38 country and most of them were categorized as susceptible by the current clinical quinolone 39 susceptibility breakpoints. We developed a disk diffusion-based method to improve the 40 phenotypic detection of aac(6')-Ib-cr. The most frequent PMQR genes in our collection 41 (qnrB19, qnrB10, aac(6')-Ib-cr) were differentially distributed among enterobacterial species 42 and two different epidemiological settings were evident. First, the species associated to 43 community-acquired infections (Salmonella spp. and Escherichia coli) mainly harbored 44 qnrB19 (unique PMQR gene) located in small ColE1-type plasmids that might constitute its 45 natural reservoirs. qnrB19 was not associated to an extended-spectrum-β-lactamase 46 phenotype. Second, the species associated to hospital-acquired infections (Enterobacter spp., 47
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Transference of PMQR-containing plasmids was assayed by biparental conjugation with 156 E. coli J53 azide-resistant (AzR) as described before (36). Transconjugants were selected with 157 100 μg/ml of sodium azide and 100 μg/ml of ampicillin, for the isolates harboring qnrB10, 158 qnrB2 or qnrS1, or 0.12 μg/ml of ciprofloxacin for the isolates harboring qnrB19. The 159 identities of qnrS1 and the qnrB alleles were checked back in the transconjugants by DNA 160
sequencing. 161 162
Analysis of the quinolone resistance determining regions (QRDRs) of gyrA and parC. 163 The QRDRs of gyrA from the 82 isolates that showed resistance or intermediate category to 164 NAL were amplified by PCR and sequenced. The QRDRs of parC were additionally analyzed 165 in those isolates where at least one mutation associated to quinolone resistance (MAQR) (41) 166 was detected in the QRDR of gyrA (see primers used in the Supplementary Table S2 ). The 167 gyrA QRDR sequences were compared with reference sequences of E. coli, E. aerogenes, E. (GenBank accession numbers GG668576, AE014073, U56906, and AE006468, CP001113, 173 CP001120, CP001138, CP001144, respectively). The parC QRDR sequences were compared 174 with reference sequences of E. coli and K. pneumoniae (GenBank accession numbers 175 NC000913 and AF303641, respectively) (25) or with the sequences of the same quinolone-176 susceptible isolates of P. mirabilis, S. flexneri, S. marcescens and S. enterica, subsp. enterica 177 used for the gyrA QRDR comparisons (GenBank accession numbers GG668579, AE014073, 178 AF227958, and AE006468, CP001113, CP001120, CP001138, CP001144, respectively). 179
The QRDR sequences of M. morganii were compared with available sequences in7 (see Supplementary Fig. S3 ). At least one qnrB allele corresponding to each PCR- RFLP 190 profile was sequenced (complete gene). 191
The presence of aac(6')-Ib-cr and/or aac(6')-Ib, which differ in two amino acids (38), 192 was determined with separate allele-specific PCRs, using two primers sets directed against 193 each variant (see Supplementary Table S2) England BioLabs). The ligation products were used as the templates of reverse PCR using the 208 divergent primers for qnrB19 (Supplementary Table S2 ). The amplicons were cloned using 209 the TOPO TA Cloning kit (Invitrogen) under the manufacturer recommendations and the 210 inserts were sequenced using the M13 universal primers and sequence-based designed 211 primers (DNA walking). To discard possible in vitro DNA rearrangements, the genetic 212 structure was confirmed by PCR cartography in the original clinical isolates. 213
214
Nucleotide sequence accession numbers. The sequences of the QRDRs of gyrA and parC 215 from the M. morganii isolate have been deposited in the GenBank database under the 216 accession numbers KC503934 and KC503935, respectively, and the sequences of the qnrB19 217 genetic environments from E. coli M9820 and M11059 under the accession numbers 218 JX298079 and JX298080, respectively. 219 220
Results and Discussion 221
Analysis of the QRDRs of gyrA and parC. MAQRs in gyrA (41) were detected in all the 138 to NAL (disk diffusion inhibition zones of 6 mm; MICs 128->512 μg/ml). In addition, we also 224 found MAQRs in gyrA in all the NAL-resistant isolates of S. flexneri (both isolates) and P. 225 mirabilis (1 isolate) (disk diffusion inhibition zones of 9 or 13 mm and MICs of 64 or 16 226 μg/ml, respectively). Therefore, the NAL and ciprofloxacin susceptibility data of the 32 oqxA/oqxB-harboring 245 isolates of our bacterial collection were analyzed according to the PMQR genes detected 246 (Table 1) . Of note, the 14 oqxA/oqxB-harboring isolates without any known PMQR gene 247 showed a wide range of MICs and disk diffusion inhibition zones for both NAL (4 to 128 248 μg/ml and 9 to 25 mm) and ciprofloxacin (0.015 to 1 μg/ml and 15 to 29 mm). This result was 249 in agreement with a range of ciprofloxacin MICs from 0.008 to 0.25 μg/ml previously 250 observed for K. pneumoniae isolates that harbored oqxA and oqxB as the unique determinant 251 of quinolone resistance (40). It has been proposed that this lack of correlation between the 252 presence of the oqxA and oqxB genes and the level of quinolone resistance could be explained 253 by different expression levels of the oqxAB operon, due to yet-undefined regulatory elements 254 (26, 40, 50). Therefore, the analyses on PMQR genes described in the following sections were 255 carried out regardless of the presence of oqxA and oqxB. and qepA were not detected in our bacterial collection. Some of these genes were found in 280 other Latin American countries. The qnrA gene was detected in enterobacterial isolates from 281 10 9 isolates, respectively, while 15 isolates contained both. Nineteen out of the 24 isolates with 292 aac(6')-Ib-cr also harbored a qnr gene (qnrB10, 16 isolates; qnrB1, qnrB2 or qnrS1, 1 isolate 293 each) whereas in 5 isolates (3 Klebsiella spp., 1 S. marcescens and 1 M. morganii) aac(6')-Ib-294 cr was found as the unique PMQR gene. Similarly as qnrB10, aac(6')-Ib-cr was mainly found 295 in Enterobacter spp., Klebsiella spp. and S. marcescens, whereas it was almost absent in E. 296 coli and Salmonella spp. (Fig. 1) . Moreover, qnrB10 and aac(6')-Ib-cr were significantly 297 associated due to co-expression (aac(6')-Ib-cr was present in the 80% of qnrB10-harboring 298 isolates but only in 9% of those without qnrB10, P<0.0001, Fisher's test). 299
The nucleotide sequence of the aac(6')-Ib-cr variant previously found in Argentina (36) 300 differs from that originally reported by Robicsek et al. (38) in a silent change located in one of 301 the two mutations that confer catalytic activity on ciprofloxacin and norfloxacin (AGG 302 instead of CGG). In our bacterial collection, 18 of the 24 aac(6')-Ib-cr-containing isolates 303 harbored the AGG codon and only 6 of them showed the CGG codon. This fact must be taken 304 into account if the detection of aac(6')-Ib-cr is done using molecular methods based on the 305 detection of single nucleotide polymorphisms such as allele-specific PCR or RFLP (2). The 306 allele-specific PCR described here allowed us to detect not only aac(6')-Ib and aac(6')-Ib-cr 307 but also both variants of the latter. 308
The relevant antibiotic susceptibility profiles of the bacterial collection, excluding the 309 16 isolates with MAQRs, were grouped according to the PMQR genes detected ( Table 2) . The 310 MIC 50 of NAL, ciprofloxacin and levofloxacin in the group of isolates that harbors any 311 PMQR gene were 4-times higher than those in the group without a known PMQR. 312 Accordingly, the disk diffusion inhibition zones of these three quinolones were smaller in the 313 former group. However, Table 2 also shows that there was a partial overlapping between the 314 distributions of MIC or disk diffusion inhibition zone of these groups for ciprofloxacin or 315 11 aac(6')-Ib-cr by disk diffusion comparing the susceptibility to ciprofloxacin and levofloxacin. 326
As can be seen in Fig. 2 , a difference ≥5 mm between the inhibition zones of levofloxacin and 327 ciprofloxacin (Δ LVX-CIP ) was a strong predictor for the presence of aac(6')-Ib-cr. As a 328 comparison, the increase in the MIC of ciprofloxacin with respect to that of levofloxacin was 329 a worse predictor (Fig. 2) . The disk diffusion method was able to detect the presence of 330 aac(6')-Ib-cr even in the 2 isolates with MAQRs in gyrA and parC (see Fig. 2 ). Of course, 331 this method cannot be applied in those isolates without disk diffusion inhibition zones for 332 ciprofloxacin and halos ≤10 mm for levofloxacin (4). However, the detection of aac(6')-Ib-cr 333 becomes clinically irrelevant in these cases since they already are highly fluoroquinolone-334 resistant. 335
Besides the impact on quinolone susceptibility pointed out above, a relevant number of 336 PMQR-containing strains were not detected by the quinolone susceptibility breakpoints 337 defined by the CLSI (7) and the European Committee on Antimicrobial Susceptibility Testing 338 (EUCAST) (11) ( Table 3) . Thirteen percent (disk diffusion) and 23% (MIC) of PMQR-339 containing isolates showed NAL susceptibility according to CLSI. These susceptibility 340 percentages were several times higher for ciprofloxacin and the highest for levofloxacin [87% 341
(EUCAST) to 93% (CLSI), under the MIC breakpoints, or 72% (EUCAST) to 95% (CLSI) 342 for disk diffusion, Table 3 ]. Of note, only 5% and 8% of the PMQR-harboring isolates were 343 considered as wild-type (i.e., without resistance mechanisms) by using the epidemiological 344 cut-offs (ECOFFs) defined by the EUCAST from the MIC distributions of ciprofloxacin and 345 levofloxacin, respectively (12). 346 347 Genetic environments of qnrB and qnrS. As can be seen in Figure 3A to C, the qnrB2 and 348 qnrB10 alleles were associated to ISCR1 but qnrB1 and qnrB19 were not. A pspF-like gene, 349 the transcriptional activator of the stress-inducible psp operon, was found immediately 350 upstream of all the qnrB alleles (22, 36, 43, 45) . Interestingly, qnrB19 was located in 3 351 different genetic environments, which suggests that several mobile genetic elements have 352 been involved in its mobilization (Fig. 3C) . In 24 out of the 26 qnrB19-harboring isolates this 353 gene was located in 4 small highly related ColE1-type plasmids, named pPAB19-1, pPAB19-354 2, pPAB19-3 and pPAB19-4, that were fully characterized in a previous work where a model 355 for plasmid evolution has been proposed (45). The distribution of these plasmids in our 356 bacterial set was: pPAB19-1 (8 Salmonella spp. and 8 E. coli), pPAB19-2 (1 Salmonella spp. 357
and 2 E. coli), pPAB19-3 (1 E. coli) and pPAB19-4 (4 Salmonella spp.). In the remaining 212 this gene was not located in such plasmids since PCRs with the qnrB19 divergent primers and 360 those directed against the rep region (Supplementary Table S2 ) were negative (Fig. 3C) . In 361 both isolates, the 433-bp sequences located upstream of qnrB19 were identical to that found 362 in plasmid p61/9, previously described in a clinical isolate of S. enterica from Italy (9). 363 However, the downstream regions presented some differences with that in p61/9. In strain 364 M9820, the comparison to the p61/9 sequence showed that the region was interrupted by an 365 internal fragment of the tnpA of Tn1721, which in turn was truncated by a Tn3 insertion. In 366 M11059, we found the same qnrB19 downstream region as in M9820 but lacking the Tn3 367 insertion (Fig. 3C) . 368
The qnrS1 gene was not associated to ISCR1 and its genetic environment was identical 369 to others previously described (24) (Fig. 3D) . 370 371 Horizontal gene transfer. We selected 3 E. coli with qnrB19 (M9996, M9820 and M11059, 372 one for each genetic environment, see Fig. 3C ); 2 K. pneumoniae and 1 E. cloacae with 373 qnrB10 plus aac(6')-Ib-cr; 1 E. coli with qnrB2 plus aac(6')-Ib-cr, and 1 K. pneumoniae with 374 qnrS1 for mating experiments. All of these PMQR genes were transferred to the recipient 375 strain E. coli J53-AzR, which underscores their potential for horizontal dissemination. 376
Interestingly, the 4 qnrB19-harboring ColE1-type plasmids found contain an identical oriT 377 but they lack the mob and tra genes (45). Therefore, the transference of pPAB19-2 from 378 isolate M9996 to E. coli J53-AzR strongly suggests that all these highly related plasmids may 379 be mobilized even when they are not self-transferable (8). 380 381 Association to other relevant resistance mechanisms. Forty (38%) out of the 105 studied 382 isolates had an ESBL phenotype. The proportion of isolates with an ESBL phenotype in the 383
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In the remaining species of our collection, E. coli, Salmonella spp. and Shigella spp. 393 (n=47; see Fig. 1 We previously reported the co-expression of rmtD2 and qnrB10 in a clinical 398
Citrobacter freundii from Argentina (44). In the current study, none of the isolates showed the 399 typical absence of inhibition zones for both gentamicin and amikacin (10, 44) Although the sampling design used allowed us to gain some insights on the presence of 431 PMQR and oqxA/oqxB genes in Argentina it is noteworthy that our bacterial collection was 432 biased to resistance or decreased susceptibility to quinolones. Therefore, it was not possible to 433 estimate PMQR prevalence rates or to draw conclusions fully applicable to the whole clinical 434 setting. A nationwide study, using a collection of non-selected, consecutive enterobacterial 435
isolates (44) 
